The global corneal transplant market is slated to grow due to an exponential rise in the incidence of eye disorders worldwide. Moreover, there has been an acute shortage of corneal donors since the last few years, which is driving the key participants toward production of artificial corneas.
The companies operating in corneal transplant market are working toward fabricating bioengineered corneal endothelial grafts by using allogeneic cornea-derived matrix.
They are looking forward to reach out to the untapped regions in Middle East & Africa, Latin America, and Asia Pacific to widen the consumer base as well as build customers’ loyalty by being the first entrants.
A corneal transplant is referred to as an operation meant to replace a part of the cornea with a corneal tissue from donor. It is also referred to as keratoplasty. Cornea is a dome-shaped, transparent surface of eye. Light makes an entry into the eye through cornea. It plays a vital role in the ability of eye to see properly.
A corneal transplant is capable of restoring vision, reducing pain, and improving appearance of diseased or damaged cornea.
Artificial corneas are being manufactured due to shortage of corneal donors. In June 2021, EyeOn Medical received CE mark for EndoArt, its flagship product, which is the first corneal implant designed for counteracting corneal edema.
However, higher cost of ophthalmology devices and surgical procedures is bound to restrain the corneal transplant market during the forecast period.
Attribute | Detail |
---|---|
Market Drivers |
|
Rise in geriatric population has increased the risk of chronic diseases such as diabetes, which has, in turn, resulted in the onslaught of ocular disorders such as visual hypertension (glaucoma) and diabetic retinopathy.
According to the Royal National Institute of Blind People, over 2 million people in the U.K. are battling loss of eyesight, and this figure is expected to reach 4.1 million by the year 2050.
As of now, around 150 individuals are suffering from trachoma, out of which 10 million are waiting for corneal blindness. 4.9 million individuals succumb to corneal scarring in the form of complete blindness.
According to the National Center for Biotechnology Information report, 10-15% of patients who are diagnosed with keratoconus are advised to opt for corneal transplantation. The other conditions that demand corneal transplant include Fuchs dystrophy, corneal ulcers, and corneal edema.
Higher prevalence of corneal disorders is thus accelerating the corneal transplant market growth.
There is a noticeable requirement of corneal donors around the world, as research states that over 10 million people need corneal transplants. Patients in countries like India face waiting period of over 6 months for corneal transplants.
It further states that close to 6.8 million individuals in the country have imperfect vision in one eye, with 1 million people having poor vision in both the eyes owing to corneal disorders.
As per the National Institutes of Health, there is only one cornea available for 70 corneas needed worldwide. The key participants are developing bio-engineered artificial corneas to cater to this need and the biocompatibility involved.
For instance, in July 2020, CorNeat Vision developed an affordable and an easily implantable artificial cornea called CorNeat KPro. It has been designed for replacing deformed, scarred, or opacified corneas and is expected to rehabilitate vision of corneally blind patients with immediate effect.
Attribute | Detail |
---|---|
Leading Region | North America |
As per the latest corneal transplant market insights, North America held the largest share in ocular surface reconstruction landscape in 2023 and the scenario is expected to remain the same during the forecast period.
This is attributed to rise in awareness regarding eye donation in the U.S. The Eye Bank Association of America (EBAA) celebrates eye donation month every November in order to raise the awareness quotient regarding eye donation as well as transplantation.
Additionally, EBAA 2021 report states that keratoconus ends up affecting one in every 2,000 Americans every year. Furthermore, according to June 2020 statistics stated by CDC, close to 12 million individuals aged 40 and above were living with vision impairment in the U.S. in 2020.
This higher prevalence of ocular disorders is likely to help North America continue with its dominance in the global corneal transplant market.
The companies in corneal transplant market are involved in new product launch to make up for the death of corneal donors. For instance, in January 2020, Mediphacos announced that it had released Keraring’s intrastromal corneal ring in order to widen its customer base. In June 2020, AJL Ophthalmic received CE Mark approval for its ENDO-K PRO.
Corneal transplant market report highlights CryoLife, Inc., ExaTech, Inc., Köhler GmbH, Lifeline Scientific Inc, LifeCell, Medtronic, DIOPTEX Medizinprodukte, Presbia Plc, KeraMed, Inc., and LinkoCare Life Sciences AB based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
Attribute | Detail |
---|---|
Market Size in 2023 | US$ 444.3 Mn |
Market Forecast (Value) in 2034 | US$ 805.8 Mn |
Growth Rate (CAGR) | 5.6% |
Forecast Period | 2024-2034 |
Historical Data Available for | 2020-2022 |
Quantitative Units | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available Upon Request |
Pricing | Available Upon Request |
It was valued at US$ 444.3 Mn in 2023
It is projected to grow at a CAGR of 5.6% from 2024 to 2034
Growing prevalence of corneal blindness and shortage of corneal donors
Eye clinics segment accounted for the largest share in 2023
North America was the dominant region in 2023
CryoLife, Inc., ExaTech, Inc., Köhler GmbH, Lifeline Scientific Inc, LifeCell, Medtronic, DIOPTEX Medizinprodukte, Presbia Plc, KeraMed, Inc., and LinkoCare Life Sciences AB
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Corneal Transplant Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Corneal Transplant Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Corneal Transplant Market Analysis and Forecast, by Procedure Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Procedure Type, 2020-2034
6.3.1. Penetrating Keratoplasty
6.3.2. Endothelial Keratoplasty
6.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
6.3.4. Corneal Graft
6.3.5. Corneal Limbal Stem Cell Transplant
6.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
6.4. Market Attractiveness Analysis, by Procedure Type
7. Global Corneal Transplant Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2020-2034
7.3.1. Fungal Corneal Ulcer
7.3.2. Bullous Keratopathy
7.3.3. Keratoconus
7.3.4. Keratitis
7.3.5. Others (Corneal Perforation, etc.)
7.4. Market Attractiveness Analysis, by Indication
8. Global Corneal Transplant Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Eye Clinics
8.3.3. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Corneal Transplant Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Corneal Transplant Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Procedure Type, 2020-2034
10.3.1. Penetrating Keratoplasty
10.3.2. Endothelial Keratoplasty
10.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
10.3.4. Corneal Graft
10.3.5. Corneal Limbal Stem Cell Transplant
10.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
10.4. Market Value Forecast, by Indication, 2020-2034
10.4.1. Fungal Corneal Ulcer
10.4.2. Bullous Keratopathy
10.4.3. Keratoconus
10.4.4. Keratitis
10.4.5. Others (Corneal Perforation, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Eye Clinics
10.5.3. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Procedure Type
10.7.2. By Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Corneal Transplant Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Procedure Type, 2020-2034
11.3.1. Penetrating Keratoplasty
11.3.2. Endothelial Keratoplasty
11.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
11.3.4. Corneal Graft
11.3.5. Corneal Limbal Stem Cell Transplant
11.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
11.4. Market Value Forecast, by Indication, 2020-2034
11.4.1. Fungal Corneal Ulcer
11.4.2. Bullous Keratopathy
11.4.3. Keratoconus
11.4.4. Keratitis
11.4.5. Others (Corneal Perforation, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Eye Clinics
11.5.3. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Procedure Type
11.7.2. By Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Corneal Transplant Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Procedure Type, 2020-2034
12.3.1. Penetrating Keratoplasty
12.3.2. Endothelial Keratoplasty
12.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
12.3.4. Corneal Graft
12.3.5. Corneal Limbal Stem Cell Transplant
12.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
12.4. Market Value Forecast, by Indication, 2020-2034
12.4.1. Fungal Corneal Ulcer
12.4.2. Bullous Keratopathy
12.4.3. Keratoconus
12.4.4. Keratitis
12.4.5. Others (Corneal Perforation, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Eye Clinics
12.5.3. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Procedure Type
12.7.2. By Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Corneal Transplant Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Procedure Type, 2020-2034
13.3.1. Penetrating Keratoplasty
13.3.2. Endothelial Keratoplasty
13.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
13.3.4. Corneal Graft
13.3.5. Corneal Limbal Stem Cell Transplant
13.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
13.4. Market Value Forecast, by Indication, 2020-2034
13.4.1. Fungal Corneal Ulcer
13.4.2. Bullous Keratopathy
13.4.3. Keratoconus
13.4.4. Keratitis
13.4.5. Others (Corneal Perforation, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Eye Clinics
13.5.3. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Procedure Type
13.7.2. By Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Corneal Transplant Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Procedure Type, 2020-2034
14.3.1. Penetrating Keratoplasty
14.3.2. Endothelial Keratoplasty
14.3.3. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
14.3.4. Corneal Graft
14.3.5. Corneal Limbal Stem Cell Transplant
14.3.6. Others (Deep Anterior Lamellar Keratoplasty, etc.)
14.4. Market Value Forecast, by Indication, 2020-2034
14.4.1. Fungal Corneal Ulcer
14.4.2. Bullous Keratopathy
14.4.3. Keratoconus
14.4.4. Keratitis
14.4.5. Others (Corneal Perforation, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Eye Clinics
14.5.3. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Procedure Type
14.7.2. By Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. CryoLife, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. ExaTech, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Köhler GmbH
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Lifeline Scientific Inc
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. LifeCell
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Medtronic
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. DIOPTEX Medizinprodukte
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Presbia Plc
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. KeraMed, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. LinkoCare Life Sciences AB
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 02: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 03: Global Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Corneal Transplant Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 07: North America Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 08: North America Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 11: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 12: Europe Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 15: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 16: Asia Pacific Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 19: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 20: Latin America Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Procedure Type, 2020-2034
Table 23: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 24: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Corneal Transplant Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Corneal Transplant Market Revenue (US$ Mn), by Procedure Type, 2023
Figure 03: Global Corneal Transplant Market Value Share, by Procedure Type, 2023
Figure 04: Global Corneal Transplant Market Revenue (US$ Mn), by Indication, 2023
Figure 05: Global Corneal Transplant Market Value Share, by Indication, 2023
Figure 06: Global Corneal Transplant Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Corneal Transplant Market Value Share, by End-user, 2023
Figure 08: Global Corneal Transplant Market Value Share, by Region, 2023
Figure 09: Global Corneal Transplant Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 11: Global Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 13: Global Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 14: Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Corneal Transplant Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Corneal Transplant Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Corneal Transplant Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 22: North America Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 23: North America Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 26:North America Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 31: Europe Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 32: Europe Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 35: Europe Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 40: Asia Pacific Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 41: Asia Pacific Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 44: Asia Pacific Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Corneal Transplant Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 49: Latin America Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 50: Latin America Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 53: Latin America Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Corneal Transplant Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Procedure Type, 2023 and 2034
Figure 58: Middle East & Africa Corneal Transplant Market Value Share Analysis, by Indication, 2023 and 2034
Figure 59: Middle East & Africa Corneal Transplant Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by Indication, 2024-2034
Figure 62: Middle East & Africa Corneal Transplant Market Attractiveness Analysis, by End-user, 2024-2034